2022
DOI: 10.1016/j.ejmech.2022.114499
|View full text |Cite
|
Sign up to set email alerts
|

trans, trans-2-C-Aryl-3,4-dihydroxypyrrolidines as potent and selective β-glucosidase inhibitors: Pharmacological chaperones for Gaucher disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 45 publications
0
4
0
Order By: Relevance
“…Compound 31 -assisted folding of mutant enzyme prevents its degradation by the ER proteostasis function. 96 Compound 32 also strongly inhibited β-glucosidase. 97 Similarly, a defect in lysosomal α-galactosidase A (α-Gal A) causes Fabry disease due to accumulation of neutral glycosphingolipids bearing a terminal α-galactosyl residue.…”
Section: Miscellaneous Diseasesmentioning
confidence: 96%
“…Compound 31 -assisted folding of mutant enzyme prevents its degradation by the ER proteostasis function. 96 Compound 32 also strongly inhibited β-glucosidase. 97 Similarly, a defect in lysosomal α-galactosidase A (α-Gal A) causes Fabry disease due to accumulation of neutral glycosphingolipids bearing a terminal α-galactosyl residue.…”
Section: Miscellaneous Diseasesmentioning
confidence: 96%
“…1,4-Dideoxy-1,4-imino- d -arabinitol ( 1 , DAB) is among the most studied iminosugars due to its widespread isolation from various sources 1–3 and significant glycosidase inhibition. The trihydroxylated pyrrolidine shows potent inhibition against yeast α-glucosidase, 2,4–9 rat intestinal sucrase, 9 α,α-trehalase 9,10 and glycogen phosphorylase, 11 and is also found to be a moderate or weak inhibitor of a series of α-glucosidases from various sources, 9,10,12 β-glucosidase, 10,12 α-mannosidase 10,12 and amyloglucosidase. 12 In contrast, many naturally occurring and synthetic derivatives of DAB have been found with the tendency of narrowing down their inhibition spectra.…”
Section: Introductionmentioning
confidence: 99%
“…When the modification strategy was applied at the C-4 position, compounds 10–13 showed potent and specific α-glucosidase inhibition, 21 whereas the C-4 hydroxymethyl depleted C -arylated DABs 14 were powerful and selective human β-glucocerebrosidase inhibitors. 9 The two series of C-4 modified derivatives of DAB ( 10 , 11 , 13 and 14 ) not only help understand the interaction modes of DAB derivatives with the corresponding enzymes, but also unveiled the potential of realizing more possibilities with further C-4 structural modifications (Fig. 1).…”
Section: Introductionmentioning
confidence: 99%
“…15 Similarly, DAB ( 8a ), the analogue of DMDP ( 3 ) was also a strong and competitive inhibitor of yeast α-glucosidase 16 and glycogen phosphorylase, 17 and also a potent inhibitor of porcine kidney trehalase. 18 Therefore, the C-5 hydroxymethyl groups of these compounds might have different influences on their binding conformations and glycosidase inhibitions. As another derivation strategy of DNJ ( 1 ), DMJ ( 2 ) and DMDP ( 3 ), C -branched iminosugars 11–13 were developed with the original hydroxymethyls used as substituents.…”
Section: Introductionmentioning
confidence: 99%